Profile
Christopher Bebbington was the founder of Allakos, Inc. which was founded in 2012, where he held the title of President & Chief Executive Officer.
Dr. Bebbington is also the founder of Celscia Therapeutics, Inc. Dr. Bebbington's former jobs include Director-Molecular Immunology at Coulter Pharmaceuticals, Inc., Senior Research Director at Corixa Corp., Vice President-Research at Humanigen, Inc., and Head-Mammalian Expression Division at Celltech Ltd.
Dr. Bebbington received his undergraduate, graduate, and doctorate degrees from the University of Oxford.
Former positions of Christopher Bebbington
| Companies | Position | End |
|---|---|---|
| ALLAKOS INC. | Chief Executive Officer | - |
| HUMANIGEN, INC. | Chief Tech/Sci/R&D Officer | - |
Celscia Therapeutics, Inc.
 Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celscia Therapeutics, Inc. is a company that researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases. The company is based in South San Francisco, CA. The company was founded by Geoffrey Thomas Yarranton, Christopher Bebbington. Celscia Therapeutics was acquired by Humanigen, Inc. on January 12, 2004. | Founder | - |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Chief Tech/Sci/R&D Officer | - |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Corporate Officer/Principal | - |
Training of Christopher Bebbington
| University of Oxford | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| ALLAKOS INC. | Health Technology |
| Private companies | 4 |
|---|---|
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Celscia Therapeutics, Inc.
Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celscia Therapeutics, Inc. is a company that researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases. The company is based in South San Francisco, CA. The company was founded by Geoffrey Thomas Yarranton, Christopher Bebbington. Celscia Therapeutics was acquired by Humanigen, Inc. on January 12, 2004. | Commercial Services |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
- Stock Market
- Insiders
- Christopher Bebbington
